iZafe Group AB (publ) (IZAFE-B.ST)
SEK 0.25
(0.0%)
SEK 0.25
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 34.61 Million SEK | -31.73% |
| 2022 | 50.7 Million SEK | 4.69% |
| 2021 | 48.42 Million SEK | 38.05% |
| 2020 | 35.08 Million SEK | -51.11% |
| 2019 | 71.75 Million SEK | 64.64% |
| 2018 | 43.58 Million SEK | 217.78% |
| 2017 | 13.71 Million SEK | 69.47% |
| 2016 | 8.09 Million SEK | -34.85% |
| 2015 | 12.42 Million SEK | -17.76% |
| 2014 | 15.1 Million SEK | -11.7% |
| 2013 | 17.1 Million SEK | -29.02% |
| 2012 | 24.1 Million SEK | 577.71% |
| 2011 | 3.55 Million SEK | -26.87% |
| 2010 | 4.86 Million SEK | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 29.39 Million SEK | -15.07% |
| 2024 Q2 | 28.11 Million SEK | -4.38% |
| 2024 Q3 | 26.97 Million SEK | -4.04% |
| 2023 Q2 | 57.72 Million SEK | -7.55% |
| 2023 Q4 | 34.61 Million SEK | -32.83% |
| 2023 Q3 | 51.53 Million SEK | -10.72% |
| 2023 FY | 34.61 Million SEK | -31.73% |
| 2023 Q1 | 62.43 Million SEK | 23.15% |
| 2022 Q3 | 30.08 Million SEK | -13.6% |
| 2022 FY | 50.7 Million SEK | 4.69% |
| 2022 Q1 | 41.69 Million SEK | -13.91% |
| 2022 Q2 | 34.81 Million SEK | -16.49% |
| 2022 Q4 | 50.7 Million SEK | 68.55% |
| 2021 Q1 | 41.38 Million SEK | 17.98% |
| 2021 FY | 48.42 Million SEK | 38.05% |
| 2021 Q4 | 48.42 Million SEK | -43.09% |
| 2021 Q3 | 85.09 Million SEK | 114.4% |
| 2021 Q2 | 39.68 Million SEK | -4.11% |
| 2020 Q4 | 35.08 Million SEK | -11.62% |
| 2020 Q1 | 53.85 Million SEK | -24.94% |
| 2020 Q2 | 53.47 Million SEK | -0.71% |
| 2020 Q3 | 39.69 Million SEK | -25.78% |
| 2020 FY | 35.08 Million SEK | -51.11% |
| 2019 Q3 | 54.34 Million SEK | -4.39% |
| 2019 FY | 71.75 Million SEK | 64.64% |
| 2019 Q4 | 71.75 Million SEK | 32.04% |
| 2019 Q1 | 45.93 Million SEK | 5.4% |
| 2019 Q2 | 56.83 Million SEK | 23.73% |
| 2018 Q4 | 43.58 Million SEK | 28.31% |
| 2018 FY | 43.58 Million SEK | 217.78% |
| 2018 Q2 | 17.32 Million SEK | 41.78% |
| 2018 Q3 | 33.96 Million SEK | 96.03% |
| 2018 Q1 | 12.22 Million SEK | -10.89% |
| 2017 FY | 13.71 Million SEK | 69.47% |
| 2017 Q1 | 7.45 Million SEK | -7.87% |
| 2017 Q2 | 10.62 Million SEK | 42.51% |
| 2017 Q3 | 9.39 Million SEK | -11.62% |
| 2017 Q4 | 13.71 Million SEK | 46.04% |
| 2016 Q2 | 11.7 Million SEK | 0.0% |
| 2016 Q4 | 8.09 Million SEK | 0.0% |
| 2016 FY | 8.09 Million SEK | -34.85% |
| 2016 Q1 | - SEK | -100.0% |
| 2015 Q1 | 14 Million SEK | -7.25% |
| 2015 FY | 12.42 Million SEK | -17.76% |
| 2015 Q4 | 12.42 Million SEK | 0.0% |
| 2015 Q3 | 12.42 Million SEK | 27.97% |
| 2015 Q2 | 9.7 Million SEK | -30.72% |
| 2014 Q3 | 16.64 Million SEK | 3.93% |
| 2014 Q1 | 20.95 Million SEK | 22.49% |
| 2014 Q2 | 16.01 Million SEK | -23.57% |
| 2014 FY | 15.1 Million SEK | -11.7% |
| 2014 Q4 | 15.1 Million SEK | -9.25% |
| 2013 Q1 | 23.35 Million SEK | -3.12% |
| 2013 Q4 | 17.1 Million SEK | -22.67% |
| 2013 Q3 | 22.12 Million SEK | -2.54% |
| 2013 Q2 | 22.69 Million SEK | -2.8% |
| 2013 FY | 17.1 Million SEK | -29.02% |
| 2012 FY | 24.1 Million SEK | 577.71% |
| 2012 Q3 | 24.62 Million SEK | 0.0% |
| 2012 Q4 | 24.1 Million SEK | -2.11% |
| 2011 FY | 3.55 Million SEK | -26.87% |
| 2010 FY | 4.86 Million SEK | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| AddLife AB (publ) | 12.74 Billion SEK | 99.728% |
| Biotage AB (publ) | 4.93 Billion SEK | 99.298% |
| Bonesupport Holding AB (publ) | 688.81 Million SEK | 94.975% |
| Doxa AB (publ) | 3.75 Billion SEK | 99.078% |
| Elekta AB (publ) | 31.41 Billion SEK | 99.89% |
| Ortivus AB (publ) | 72.7 Million SEK | 52.392% |
| Ortivus AB (publ) | 72.7 Million SEK | 52.392% |
| Q-linea AB (publ) | 231.97 Million SEK | 85.079% |
| S2Medical AB (publ) | 21.4 Million SEK | -61.692% |
| Synsam AB (publ) | 8.03 Billion SEK | 99.569% |